Diabetes: (Autonomic) Neuropathy (DAN)

Diabetic Autonomic Neuropathy (DAN) is a serious complication of long-standing diabetes, affecting the autonomic nervous system (ANS). It disrupts involuntary control of cardiovascular, gastrointestinal, genitourinary, sudomotor, and pupillary systems. ⚠️ DAN increases morbidity and mortality, especially via silent myocardial ischaemia and arrhythmias. Early recognition is essential for intervention and prevention of complications.

⚙️ Aetiology & Pathophysiology

• 🍬 Chronic Hyperglycaemia: accumulation of advanced glycation end-products (AGEs).
• 🔥 Oxidative Stress: free radical injury damages Schwann cells & microvasculature.
• 💧 Polyol Pathway: glucose → sorbitol → osmotic/oxidative stress.
• 🩸 Ischaemia: microvascular disease reduces nerve blood flow.
• 🧬 Inflammation & Neurohormonal dysfunction: impaired trophic support accelerates degeneration.

🩺 Clinical Presentation (by system)

• ❤️ Cardiovascular: resting tachycardia, orthostatic hypotension, silent ischaemia, ↓ exercise tolerance, sudden cardiac death risk.
• 🍽️ Gastrointestinal: gastroparesis (nausea, bloating, erratic glycaemia), diarrhoea, constipation, faecal incontinence.
• 💧 Genitourinary: neurogenic bladder (retention, frequency, incontinence), erectile dysfunction, retrograde ejaculation, female sexual dysfunction.
• 💦 Sweat Glands: anhidrosis in feet (ulcer risk), compensatory hyperhidrosis, heat intolerance.
• 👁️ Pupils: sluggish light reflex, poor dark adaptation → night vision difficulty.
• ⚡ Metabolic: hypoglycaemia unawareness (loss of adrenergic warning signs).

🔍 Differential Diagnosis

• 🍺 Alcoholic neuropathy
• 🧬 Amyloidosis, hereditary autonomic neuropathies
• 🛡️ Immune-mediated neuropathies (e.g. Guillain–Barré)
• 🦠 Infectious causes: HIV, Lyme, Chagas
• 💊 Drug-induced: chemotherapy, antiretrovirals, amiodarone

🧪 Investigations

• 🩺 Bedside: postural BP/HR, Valsalva manoeuvre, symptom review.
• ❤️ Cardiac: HR variability, tilt-table, Holter monitoring.
• 🍽️ GI: gastric emptying scan, wireless motility capsule, SIBO breath test.
• 💧 GU: urodynamics, post-void residual, penile Doppler.
• 💦 Sweat tests: QSART, thermoregulatory sweat test.
• 👁️ Pupillometry: light/dark reflex testing.
• 🧪 Bloods: HbA1c, renal/liver function, TFTs.
• ⚡ Nerve conduction studies: to detect concurrent peripheral neuropathy.

💊 Management

• 🩸 Glycaemic control: slows progression; avoid hypoglycaemia if awareness impaired.
• ❤️ Cardiovascular: - Orthostatic hypotension → fluids, salt, compression stockings; drugs: midodrine, fludrocortisone. - Resting tachycardia → beta-blockers. - Silent ischaemia → stress ECG screening, cautious beta-blockade.
• 🍽️ Gastrointestinal: - Gastroparesis → small, low-fat meals; prokinetics (metoclopramide, domperidone), erythromycin. - Constipation → hydration, fibre, laxatives. - Diarrhoea → loperamide, antibiotics for SIBO.
• 💧 Genitourinary: - Neurogenic bladder → timed voiding, ISC (self-catheterisation), anticholinergics. - Erectile dysfunction → PDE-5 inhibitors (sildenafil), vacuum devices, injections. - Female dysfunction → lubricants, counselling, specialist input.
• 💦 Sweat dysfunction: emollients for anhidrosis, aluminium chloride for hyperhidrosis.
• 👁️ Pupil dysfunction: sunglasses, enhanced lighting.
• ⚡ Hypoglycaemia unawareness: CGM, adjusted insulin regimens.
• 🌱 Lifestyle: smoking cessation, reduce alcohol, regular exercise, healthy diet.
• 🤝 Education & MDT: empower self-recognition; involve cardiology, gastro, urology, podiatry.

📉 Prognosis

DAN is often progressive and irreversible, but tight glycaemic control and aggressive CV risk reduction can slow decline. Mortality is increased, largely due to arrhythmia and silent myocardial infarction.

💡 Teaching Pearls

💡 Silent MI is a key cause of sudden death in DAN → maintain high suspicion.
💡 Orthostatic hypotension = one of the earliest signs of cardiovascular autonomic neuropathy.
💡 Hypoglycaemia unawareness is a red flag complication → always adjust therapy.
💡 DAN is a marker of severe, systemic microvascular disease → screen for nephropathy & retinopathy too.

📚 References

• Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115(3):387-397.
• Pop-Busui R, et al. Diabetic Neuropathy: ADA Position Statement. Diabetes Care. 2017;40(1):136-154.
• Spallone V, et al. Diabetic autonomic neuropathy: a critical review. Clin Auton Res. 2019;29(4):373-391.
• NICE NG17: Type 1 diabetes in adults (2015).
• NICE NG28: Type 2 diabetes in adults (2015).